Annexon (NASDAQ:ANNX) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline a set of ...

The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

As 2025 draws to a close, Education Secretary Sonny Angara said the Department of Education (DepEd) has laid key system reforms aimed at producing work-ready graduates and sustaining long-term ...

今年的STS竞赛，共有超过 2600名学生提交申请，他们来自46个州、华盛顿特区、北马里亚纳群岛、波多黎各以及全球16个国家的826所高中。经过激烈角逐，最终有300位年轻人脱颖而出，入选本届学者名单—— ...

IonQ, Inc. (NYSE: IONQ) plans to deliver a quantum computer to support hybrid research efforts in South Korea. The company announced plans to ship a 100-qubit IonQ Tempo system to a national research ...